Lee's Pharmaceutical Holdings Limited
HKSE: 0950.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Siu Fong Lee
- Employees
- 1,022
- Headquarters
- Sha Tin, Hong Kong SAR China
- IPO year
- 2002
- Market cap
- HK$683.0M
- Website
- https://www.leespharm.com
Loading 0950…
Loading profile data…Frequently asked questions about 0950
What does Lee's Pharmaceutical Holdings Limited (0950.HK) do?
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It...
Where does 0950.HK trade?
Lee's Pharmaceutical Holdings Limited (0950.HK) trades on the Hong Kong Stock Exchange.
What sector is 0950.HK in?
Lee's Pharmaceutical Holdings Limited (0950.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lee's Pharmaceutical Holdings Limited?
Siu Fong Lee is the chief executive officer of Lee's Pharmaceutical Holdings Limited (0950.HK).
Where is Lee's Pharmaceutical Holdings Limited headquartered?
Lee's Pharmaceutical Holdings Limited is headquartered in Hong Kong SAR China.
Does 0950.HK pay a dividend?
Yes — Lee's Pharmaceutical Holdings Limited (0950.HK) paid a trailing twelve-month dividend of HKD 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0950.HK go public?
Lee's Pharmaceutical Holdings Limited (0950.HK) completed its initial public offering in 2002.